Medicare Enrolled

Dr. Thomas Byrd, MD

Ophthalmology · Wyandotte, MI
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
100 OAK ST, Wyandotte, MI 48192
7342842444
In practice since 2006 (20 years)
NPI: 1326011792 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Byrd from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Byrd? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Byrd

Dr. Thomas Byrd is an ophthalmology specialist in Wyandotte, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Byrd performed 2,420 Medicare services across 2,042 unique beneficiaries.

Between the years covered by Open Payments, Dr. Byrd received a total of $18,980 from 32 pharmaceutical and/or device companies across 232 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Byrd is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 31% volume in MI $18,980 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,420
Medicare services
Top 31% in MI for ophthalmology
2,042
Unique beneficiaries
$91
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~121 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
731 $82 $195
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
453 $65 $150
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
202 $28 $100
Optic nerve imaging (OCT scan)
Imaging of the optic nerve.
176 $26 $90
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
166 $45 $140
Corneal topography and eye depth measurement
This procedure measures the curvature and depth of the cornea, the clear front surface of the eye.
165 $29 $104
Cataract surgery with lens implant
Surgical removal of the clouded natural lens of the eye and replacement with an artificial prosthetic lens to restore vision.
157 $425 $1,500
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
119 $98 $200
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
95 $77 $180
Laser removal of recurring cataract
A laser procedure to remove a recurring cataract within the lens capsule.
76 $254 $700
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
31 $59 $130
Eye drainage system examination
An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye.
18 $21 $70
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
17 $115 $225
Ultrasound scan of cornea to determine thickness
An ultrasound procedure used to measure the thickness of the cornea.
14 $8 $27
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.5% high complexity
16.2% medium
77.3% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$18,980
Total received (2018-2024)
Avg $2,711/year across 7 years
Top 5% in MI for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
232
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$12,598 (66.4%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,382 (33.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$711
2023
$882
2022
$657
2021
$1,311
2020
$900
2019
$7,355
2018
$7,164

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alcon Vision LLC
$364
Bausch & Lomb Americas Inc.
$77
SUN PHARMACEUTICAL INDUSTRIES INC.
$68
Ocular Therapeutix, Inc.
$38
BIOTISSUE HOLDINGS INC.
$30
Oyster Point Pharma, Inc.
$28
RxSight Inc
$26
Rayner Intraocular Lenses Limited
$25
Amgen Inc.
$20
Sight Sciences, Inc.
$18
ABBVIE INC.
$17
Top 3 companies account for 71.7% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan Inc.
$12,110
Alcon Vision LLC
$1,677
Aerie Pharmaceuticals, Inc.
$774
Allergan, Inc.
$717
Smith+Nephew, Inc.
$643
Alcon Laboratories Inc
$499
Sun Pharmaceutical Industries Inc.
$446
Bausch & Lomb, a division of Bausch Health US, LLC
$348
Shire North American Group Inc
$311
Bausch & Lomb Americas Inc.
$212
Novartis Pharmaceuticals Corporation
$207
Oyster Point Pharma, Inc.
$144
SUN PHARMACEUTICAL INDUSTRIES INC.
$132
Optos, Inc.
$120
ABBVIE INC.
$69
Sight Sciences, Inc.
$66
NEW WORLD MEDICAL,INC.
$63
Kala Pharmaceuticals, Inc.
$59
AbbVie Inc.
$47
RxSight Inc
$40
Dompe US, Inc.
$39
Ocular Therapeutix, Inc.
$38
BIOTISSUE HOLDINGS INC.
$30
Integra LifeSciences Corporation
$27
Rayner Intraocular Lenses Limited
$25
Johnson & Johnson Surgical Vision, Inc.
$24
Mallinckrodt LLC
$23
Amgen Inc.
$20
Carl Zeiss Meditec AG
$19
Beaver-Visitec International, Inc.
$19
Pinnacle, Inc
$14
Horizon Therapeutics plc
$12
Top 3 companies account for 76.7% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVEFOCUS · ALPHAGAN P · AcrySof IQ PanOptix · AcrySof IQ PanOptix UV IOL · AcrySof IQ VIVITY · AcrySof IQ VIVITY IOL · Ahmed Glaucoma Valve · BESIVANCE · BROMSITE · BromSite (bromfenac ophthalmic solution) 0.075% · CEQUA · COMBIGAN · Cequa · Clareon · DEXTENZA · DUREZOL · DURYSTA · HYDRUS Microstent · INVELTYS · Kahook Dual Blade · LIGHT ADJUSTABLE LENS (LAL) AND LIGHT DELIVERY DEVICE (LDD) · LOTEMAX · LOTEMAX SM · LUMIGAN · MIEBO · NFC-700 · NGENUITY · None Specified · OMNI · OMNI SURGICAL SYSTEM · OMNI(R) SURGICAL SYSTEM (US) · OXERVATE · PanOptix · RAYNER CATARACT SET 1 · RESTASIS · RESTASIS MULTIDOSE · RXSIGHT CONTACT LENS · ReSTOR · Rhopressa · Rocklatan · SALTO TALARIS TOTAL ANKLE PROSTHESIS · Simbrinza · TEPEZZA · TYRVAYA · Tecnis Multifocal Family of 1-piece IOLS · VUITY · VYZULTA · XELPROS · XELPROS (latanoprost ophthalmic emulsion) 0.005% · XIIDRA · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (66%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for ophthalmology in MI.

Looking for an ophthalmology specialist in Wyandotte?
Compare ophthalmologists in the Wyandotte area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
298
Per 100K population
16.8
County median income
$59,521
Nearest hospital
WYANDOTTE HOSPITAL AND MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Byrd is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 5% of MI peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Byrd experienced with comprehensive eye exam, established patient?
Based on Medicare claims data, Dr. Byrd performed 731 comprehensive eye exam, established patient services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Byrd receive payments from pharmaceutical companies?
Yes. Dr. Byrd received a total of $18,980 from 32 companies across 232 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Byrd's costs compare to other ophthalmologists in Wyandotte?
Dr. Byrd's average Medicare payment per service is $91. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Byrd) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →